Literature DB >> 6590573

Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL).

P Brouwers, R Riccardi, D Poplack, P Fedio.   

Abstract

Simple alerted auditory reaction time (SRT) behavior with various foreperiods was investigated in a group of long-term survivors of childhood ALL who were in continuous first remission. As part of therapy, the patients had received cranial irradiation and intrathecal chemotherapy to prevent the development of central nervous system leukemia. The patients were divided into three groups on the basis of CT brain scan findings: (1) those with normal CT scans (n = 10); (2) those with evidence of cortical atrophy (n = 8), and (3) those with intracerebral calcifications (n = 5). The SRT results indicated significant differences between patients with normal and abnormal CT scans. Specifically, patients with abnormal scans reacted slower, and this latency was exaggerated by increasing the length of the warning interval. Furthermore, they reacted with larger variability which increased with the prolongation of testing. Moreover, the severity of impairment was related to the type of CT-scan abnormality: patients with calcifications performed more poorly than patients with evidence of atrophy. The present results revealed a strong correlation between the presence and type of CT-scan abnormalities and attentional performance in long-term survivors of childhood ALL.

Entities:  

Mesh:

Year:  1984        PMID: 6590573     DOI: 10.1080/01688638408401222

Source DB:  PubMed          Journal:  J Clin Neuropsychol        ISSN: 0165-0475


  12 in total

1.  Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia.

Authors:  Ida M Moore; Marilyn J Hockenberry; Cynthia Anhalt; Kathy McCarthy; Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2011-09-21       Impact factor: 3.167

2.  Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.

Authors:  Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-15       Impact factor: 2.475

Review 3.  Late effects of total body irradiation.

Authors:  A D Leiper
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

4.  Impairment of neuropsychological functions in children with medulloblastomas and astrocytomas in the posterior fossa.

Authors:  D Riva; C Pantaleoni; N Milani; F Fossati Belani
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

5.  Attentional ability among survivors of leukaemia.

Authors:  J Rodgers; J Horrocks; P G Britton; J Kernahan
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

6.  Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukaemia.

Authors:  R E Appleton; K Farrell; J Zaide; P Rogers
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

7.  Prediction of neurocognitive outcome in adult brain tumor patients.

Authors:  Thomas A Kaleita; David K Wellisch; Timothy F Cloughesy; Judith M Ford; Donald Freeman; Thomas R Belin; Jeffrey Goldman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program.

Authors:  Ping Zou; Yimei Li; Heather M Conklin; Raymond K Mulhern; Robert W Butler; Robert J Ogg
Journal:  Arch Clin Neuropsychol       Date:  2012-10-18       Impact factor: 2.813

9.  Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy.

Authors:  V Anderson; E Smibert; H Ekert; T Godber
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

10.  Intellectual performance after presymptomatic cranial radiotherapy for leukaemia: effects of age and sex.

Authors:  D Christie; A D Leiper; J M Chessells; F Vargha-Khadem
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.